Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 3/20 | 0.58 |
| ▸ | MGLL | Q99685 | 2/20 | 0.58 |
| ▸ | CA1 | P00915 | 2/20 | 0.58 |
| ▸ | MAPT | P10636 | 2/20 | 0.55 |
| ▸ | LMNA | P02545 | 1/20 | 0.55 |
| ▸ | QDPR | P09417 | 1/20 | 0.46 |
| ▸ | ENPP2 | Q13822 | 3/20 | 0.46 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.46 |
| ▸ | KIF11 | P52732 | 2/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | LPL | P06858 | 1/20 | 0.44 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | ERN1 | O75460 | 1/20 | 0.42 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.42 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.42 |
| ▸ | CA4 | P22748 | 1/20 | 0.42 |
| ▸ | CA6 | P23280 | 1/20 | 0.42 |
| ▸ | CA5A | P35218 | 1/20 | 0.42 |
| ▸ | CA7 | P43166 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phenylboronic Acid SCHEMBL28990002 | 0.91 | MGLL (0.68) | CA2MGLLCA1MAPTLMNA | |
| SCHEMBL30168342 | 0.87 | CA2 (0.45) | CA2MGLLCA1MAPTLMNA | |
| SCHEMBL5182 | 0.84 | — | — | |
| SCHEMBL18394607 | 0.84 | CA2 (0.78) | CA2MGLLCA1ENPP2TSHR | |
| SCHEMBL13667445 | 0.84 | CA2 (0.78) | CA2MGLLCA1ENPP2TSHR | |
| SCHEMBL806835 | 0.84 | CA2 (0.78) | CA2MGLLCA1ENPP2TSHR | |
| SCHEMBL23331884 | 0.83 | CA1 (0.42) | CA2MGLLCA1MAPTLMNA | |
| SCHEMBL19417431 | 0.83 | CA1 (0.57) | CA2MGLLCA1MAPTLMNA | |
| SCHEMBL7686223 | 0.81 | ENPP2 (0.48) | CA2MGLLCA1MAPTLMNA | |
| Water SCHEMBL3235248 | 0.81 | ENPP2 (0.48) | CA2MGLLCA1MAPTLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 135 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12304921-B2 | Linear boron-dipyrromethene electron donor having 180° coordination included angle and supramolecular metal macro-ring, and synthesis processes therefor and applications thereof | HANGZHOU NORMAL UNIVERSITY (CN) | 2025-05-20 | — | — | US | claimed |
| US-20250066403-A1 | LINEAR BORON-DIPYRROMETHENE ELECTRON DONOR HAVING 180º COORDINATION INCLUDED ANGLE AND SUPRAMOLECULAR METAL MACRO-RING, AND SYNTHESIS PROCESSES THEREFOR AND APPLICATIONS THEREOF | HANGZHOU NORMAL UNIVERSITY (CN) | 2025-02-27 | — | — | US | claimed |
| CN-119019386-B | Aggregation-induced emission anticancer photosensitizer and preparation method and application thereof | 香港中文大学（深圳） | 2025-01-24 | — | — | CN | claimed |
| CN-119019386-A | Aggregation-induced emission anticancer photosensitizer and preparation method and application thereof | 香港中文大学（深圳） | 2024-11-26 | — | — | CN | claimed |
| CN-117866620-A | Cucurbituril [7] -cyclodextrin cascade assembled supermolecule system for specifically detecting trivalent gold and preparation method thereof | 曲阜师范大学 | 2024-04-12 | — | — | CN | claimed |
| CN-117384159-A | Preparation method and application of long conjugated pyridinium macrocyclic photosensitizer | 暨南大学 | 2024-01-12 | — | — | CN | claimed |
| CN-114907392-B | Diamond metal ring based on BODIPY, preparation method thereof and application thereof in near infrared imaging | 杭州师范大学 | 2023-12-08 | — | — | CN | claimed |
| WO-2023159824-A1 | LINEAR BODIPY ELECTRON DONOR HAVING 180º COORDINATION INCLUDED ANGLE AND SUPRAMOLECULAR METAL MACRO-RING, AND SYNTHESIS PROCESSES THEREFOR AND USE THEREOF | 杭州师范大学 | 2023-08-31 | — | — | WO | claimed |
| CN-113896904-B | Quaternary supermolecule anti-counterfeiting system of cucurbituril [8] -diarylethene derivative-terpyridyl imidazole-europium and preparation method thereof | 曲阜师范大学 | 2023-03-24 | — | — | CN | claimed |
| CN-115433070-A | Room-temperature phosphorescent molecule based on column [5] arene and preparation method and application thereof | 浙江大学杭州国际科创中心 | 2022-12-06 | — | — | CN | claimed |
| CN-114573622-A | Linear type boron-dipyrromethene electron donor with 180-degree coordination angle, supramolecular metallare, synthesis process and application | 杭州师范大学 | 2022-06-03 | — | — | CN | claimed |
| CN-114262330-A | Fascaplysin derivative, preparation method and application thereof in MRSA resistance | 宁波大学 | 2022-04-01 | — | — | CN | claimed |
| CN-113896904-A | Quaternary supermolecule anti-counterfeiting system of cucurbituril [8] -diarylethene derivative-terpyridyl imidazole-europium and preparation method thereof | 曲阜师范大学 | 2022-01-07 | — | — | CN | claimed |
| CN-112300121-B | N-aryl substituted carbazole fluorescent probe capable of specifically labeling cell membrane and preparation method thereof | 四川大学华西医院 | 2021-07-13 | — | — | CN | claimed |
| CN-112300121-A | N-aryl substituted carbazole fluorescent probe capable of specifically labeling cell membrane and preparation method thereof | 四川大学华西医院 | 2021-02-02 | — | — | CN | claimed |
| EP-4739682-A1 | 1,6-NAPHTHRIDINE COMPOUNDS AS SMARCA2 INHIBITORS USEFUL FOR THE TREATMENT OF SMARCA4 DEFICIENT CANCERS | Janssen Pharmaceutica NV (BE) | 2026-05-13 | — | — | EP | disclosed |
| EP-4676476-A1 | INHIBITORS OF TDP-43 AND TAU AGGREGATION | Aquinnah Pharmaceuticals, Inc. (US) | 2026-01-14 | — | — | EP | disclosed |
| US-20120319087-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE CONTAINING SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2012-12-20 | — | — | US | disclosed |
| WO-2012061342-A2 | SUBSTITUTED BENZO-IMIDAZO-PYRIDO-DIAZEPINE COMPOUNDS | ARQULE, INC. (US) | 2012-05-10 | — | — | WO | disclosed |
| US-20120108574-A1 | Substituted Benzo-Imidazo-Pyrido-Diazepine Compounds | ARQULE, INC. (US) | 2012-05-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12304921-B2 | Linear boron-dipyrromethene electron donor having 180° coordination included angle and supramolecular metal macro-ring, and synthesis processes therefor and applications thereof | WEE1, WEE2, SLC39A11 | CA2 1805/4885MGLL 3400/4885CA1 2623/4885 |
| US-20120108574-A1 | Substituted Benzo-Imidazo-Pyrido-Diazepine Compounds | BRD4, BRPF3, BRD3 | CA2 3143/4885MGLL 4857/4885CA1 3854/4885 |
| US-20250066403-A1 | LINEAR BORON-DIPYRROMETHENE ELECTRON DONOR HAVING 180º COORDINATION INCLUDED ANGLE AND SUPRAMOLECULAR METAL MACRO-RING, AND SYNTHESIS PROCESSES THEREFOR AND APPLICATIONS THEREOF | WEE1, WEE2, SLC39A11 | CA2 1833/4885MGLL 3655/4885CA1 2631/4885 |
| US-20120319087-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE CONTAINING SAME | CRY1, TRPA1, SUN2 | CA2 4654/4885MGLL 1576/4885CA1 4662/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.